林子翔,男,中共党员。1995年出生,2018年毕业于中国农业大学获得农学学士学位,2023年毕业于中国农业大学获得农学博士学位。2023年8月开始在皇冠集团99442登录入口工作,从事的研究方向为小动物临床疾病治疗与肿瘤疾病研究,目前以第一作者发表文章4篇。
发表文章:
[1] Lin Z#, Chen Q#, Zhou J, Zhang J, Zhang X, Zhang D, Lin J, Lin D. Transcriptomic analysis reveals immune infiltration status and potential biomarkers of canine colorectal cancer. Vet Immunol Immunopathol. 2023 Aug;262:110622.
[2] Li X#, Lin Z#, Wang P, Zhou C, Xu J, Lin J, Lin D, Zhang D. Tetramethylpyrazine-Rhein Derivative inhibits the migration of canine inflammatory mammary carcinoma cells by mitochondrial damage-mediated apoptosis and cadherins downregulation. Biomed Pharmacother. 2023 Jun;162:114731.
[3] Lin Z#, Jiang C#, Lv D, Lin D. Identification of EDIL3 biomarkers as a biomarker and potential therapeutic target of canine mammary carcinomas based on integrated bioinformatics analysis. Vet Immunol Immunopathol. 2022 Jul;249:110432.
[4] Zhang H#, Lin Z#, Jiang Y, Qian W, Lv C, Zhang L, Wang S, Qi M, Xia Z. Molecular identification of Cryptosporidium spp. in pet snakes in Beijing, China. Parasitol Res. 2020 Sep;119(9):3119-3123.
E-mail:20239501@bua.edu.cn